King AD - Search Results

1

MRI of benign hyperplasia in the nasopharynx: is there an association with Epstein-Barr virus?

Ai QY, King AD, So TY, Lam WKJ, Mo FKF, Tse IOL, Woo JKS, Chan KCA. Ai QY, et al. Among authors: king ad. Clin Radiol. 2020 Sep;75(9):711.e13-711.e18. doi: 10.1016/j.crad.2020.05.011. Epub 2020 Jun 19. Clin Radiol. 2020. PMID: 32571521

2

Comparison of T2 weighted fat suppressed turbo spin echo and contrast enhanced T1 weighted spin echo MRI in nasopharyngeal carcinoma.

King AD, Lam WW, Leung SF, Chan YL, Metreweli C. King AD, et al. Br J Radiol. 1997 Dec;70(840):1208-14. doi: 10.1259/bjr.70.840.9505838. Br J Radiol. 1997. PMID: 9505838 Clinical Trial.

3

Palatal lymphoepitheliomas and a review of head and neck lymphoepitheliomas.

Ahuja AT, Teo PM, To KF, King AD, Metreweli C. Ahuja AT, et al. Among authors: king ad. Clin Radiol. 1999 May;54(5):289-93. doi: 10.1016/s0009-9260(99)90556-1. Clin Radiol. 1999. PMID: 10362233

4

MR imaging of thyroglossal duct cysts in adults.

King AD, Ahuja AT, Mok CO, Metreweli C. King AD, et al. Clin Radiol. 1999 May;54(5):304-8. doi: 10.1016/s0009-9260(99)90559-7. Clin Radiol. 1999. PMID: 10362236

5

Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging.

Chan YL, Leung SF, King AD, Choi PH, Metreweli C. Chan YL, et al. Among authors: king ad. Radiology. 1999 Dec;213(3):800-7. doi: 10.1148/radiology.213.3.r99dc07800. Radiology. 1999. PMID: 10580956

6

MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage.

King AD, Lam WW, Leung SF, Chan YL, Teo P, Metreweli C. King AD, et al. Br J Radiol. 1999 Aug;72(860):734-41. doi: 10.1259/bjr.72.860.10624338. Br J Radiol. 1999. PMID: 10624338

7

Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck.

King AD, Ahuja AT, To EW, Tse GM, Metreweli C. King AD, et al. Clin Radiol. 2000 Mar;55(3):222-6. doi: 10.1053/crad.1999.0373. Clin Radiol. 2000. PMID: 10708617

8

Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma.

King AD, Ahuja AT, Teo P, Tse GM, Kew J. King AD, et al. Clin Radiol. 2000 Sep;55(9):684-9. doi: 10.1053/crad.2000.0503. Clin Radiol. 2000. PMID: 10988046

9

Non-Hodgkin's lymphoma of the nasopharynx: CT and MR imaging.

King AD, Lei KI, Richards PS, Ahuja AT. King AD, et al. Clin Radiol. 2003 Aug;58(8):621-5. doi: 10.1016/s0009-9260(03)00182-x. Clin Radiol. 2003. PMID: 12887955

10

Accuracy of high-resolution sonography compared with magnetic resonance imaging in the diagnosis of head and neck venous vascular malformations.

Ahuja AT, Richards P, Wong KT, Yuen EH, King AD. Ahuja AT, et al. Among authors: king ad. Clin Radiol. 2003 Nov;58(11):869-75. doi: 10.1016/s0009-9260(03)00290-3. Clin Radiol. 2003. PMID: 14581011

11

Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US.

King AD, Tse GM, Ahuja AT, Yuen EH, Vlantis AC, To EW, van Hasselt AC. King AD, et al. Radiology. 2004 Mar;230(3):720-6. doi: 10.1148/radiol.2303030157. Radiology. 2004. PMID: 14990838

12

Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.

Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PM, Zee B. Chan AT, et al. J Clin Oncol. 2004 Aug 1;22(15):3053-60. doi: 10.1200/JCO.2004.05.178. J Clin Oncol. 2004. PMID: 15284255 Clinical Trial.

13

Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T.

King AD, Yeung DK, Ahuja AT, Yuen EH, Ho SF, Tse GM, van Hasselt AC. King AD, et al. Clin Radiol. 2005 May;60(5):592-8. doi: 10.1016/j.crad.2004.11.012. Clin Radiol. 2005. PMID: 15851048

14

Salivary gland tumors at in vivo proton MR spectroscopy.

King AD, Yeung DK, Ahuja AT, Tse GM, Yuen HY, Wong KT, van Hasselt AC. King AD, et al. Radiology. 2005 Nov;237(2):563-9. doi: 10.1148/radiol.2372041309. Radiology. 2005. PMID: 16244265

15

Magnetic resonance imaging for the detection of nasopharyngeal carcinoma.

King AD, Vlantis AC, Tsang RK, Gary TM, Au AK, Chan CY, Kok SY, Kwok WT, Lui HK, Ahuja AT. King AD, et al. AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1288-91. AJNR Am J Neuroradiol. 2006. PMID: 16775281 Free PMC article.

16

Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

Ma BB, King A, Lo YM, Yau YY, Zee B, Hui EP, Leung SF, Mo F, Kam MK, Ahuja A, Kwan WH, Chan AT. Ma BB, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):714-20. doi: 10.1016/j.ijrobp.2006.05.064. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011447

17

Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings.

King AD, Ahuja AT, Yeung DK, Wong JK, Lee YY, Lam WW, Ho SS, Yu SC, Leung SF. King AD, et al. Clin Radiol. 2007 Mar;62(3):195-203. doi: 10.1016/j.crad.2006.10.011. Clin Radiol. 2007. PMID: 17293211 Review.

18

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy.

Ma B, Hui EP, King A, To KF, Mo F, Leung SF, Kam M, Lo YM, Zee B, Mok T, Ahuja A, Chan AT. Ma B, et al. Cancer Chemother Pharmacol. 2008 Jun;62(1):59-64. doi: 10.1007/s00280-007-0575-8. Epub 2007 Aug 29. Cancer Chemother Pharmacol. 2008. PMID: 17762933 Clinical Trial.

19

Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging.

King AD, Ahuja AT, Yeung DK, Fong DK, Lee YY, Lei KI, Tse GM. King AD, et al. Radiology. 2007 Dec;245(3):806-13. doi: 10.1148/radiol.2451061804. Epub 2007 Oct 2. Radiology. 2007. PMID: 17911539

20

The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.

King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, Kam MK, Ahuja AT, Chan AT. King AD, et al. Br J Radiol. 2008 Apr;81(964):291-8. doi: 10.1259/bjr/73751469. Br J Radiol. 2008. PMID: 18344274

21

The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma.

Ma BB, Mo FK, Chan AT, Hui EP, Leung SF, Lo YM, Yau YY, King AD. Ma BB, et al. Among authors: king ad. Oral Oncol. 2008 Nov;44(11):1067-72. doi: 10.1016/j.oraloncology.2008.02.001. Epub 2008 Apr 8. Oral Oncol. 2008. PMID: 18396444

22

Nasopharyngectomy: does the approach to the nasopharynx influence survival?

Vlantis AC, Yu BK, Kam MK, Hung T, Lo PS, King AD, Tong MC, van Hasselt CA. Vlantis AC, et al. Among authors: king ad. Otolaryngol Head Neck Surg. 2008 Jul;139(1):40-6. doi: 10.1016/j.otohns.2008.04.018. Otolaryngol Head Neck Surg. 2008. PMID: 18585559

23

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.

Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT. Hui EP, et al. Among authors: king ad. J Clin Oncol. 2009 Jan 10;27(2):242-9. doi: 10.1200/JCO.2008.18.1545. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064973 Clinical Trial.

24

MRI of radiation-induced tumors of the head and neck in post-radiation nasopharyngeal carcinoma.

Abrigo JM, King AD, Leung SF, Vlantis AC, Wong JK, Tong MC, Tse GM, Ahuja AT. Abrigo JM, et al. Among authors: king ad. Eur Radiol. 2009 May;19(5):1197-205. doi: 10.1007/s00330-008-1265-6. Epub 2009 Jan 14. Eur Radiol. 2009. PMID: 19142643

25

Osteoradionecrosis of the upper cervical spine: MR imaging following radiotherapy for nasopharyngeal carcinoma.

King AD, Griffith JF, Abrigo JM, Leung SF, Yau FK, Tse GM, Ahuja AT. King AD, et al. Eur J Radiol. 2010 Mar;73(3):629-35. doi: 10.1016/j.ejrad.2008.12.016. Epub 2009 Feb 5. Eur J Radiol. 2010. PMID: 19200678

26

MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma.

Bhatia KS, King AD, Paunipagar BK, Abrigo J, Vlantis AC, Leung SF, Ahuja AT. Bhatia KS, et al. Among authors: king ad. Eur Radiol. 2009 Nov;19(11):2586-93. doi: 10.1007/s00330-009-1445-z. Epub 2009 Jun 6. Eur Radiol. 2009. PMID: 19504110

27

Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.

King AD, Yeung DK, Yu KH, Mo FK, Hu CW, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Ahuja AT. King AD, et al. Eur Radiol. 2010 Jan;20(1):165-72. doi: 10.1007/s00330-009-1531-2. Epub 2009 Aug 5. Eur Radiol. 2010. PMID: 19652977 Clinical Trial.

28

Evolution of radiation-induced brain injury: MR imaging-based study.

Wang YX, King AD, Zhou H, Leung SF, Abrigo J, Chan YL, Hu CW, Yeung DK, Ahuja AT. Wang YX, et al. Among authors: king ad. Radiology. 2010 Jan;254(1):210-8. doi: 10.1148/radiol.09090428. Epub 2009 Dec 17. Radiology. 2010. PMID: 20019142

29

Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.

King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Ahuja AT. King AD, et al. Eur Radiol. 2010 Sep;20(9):2213-20. doi: 10.1007/s00330-010-1769-8. Epub 2010 Mar 23. Eur Radiol. 2010. PMID: 20309553

30

Pretreatment and early intratreatment prediction of clinicopathologic response of head and neck cancer to chemoradiotherapy using 1H-MRS.

King AD, Yeung DK, Yu KH, Mo FK, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Hu CW, Ahuja AT. King AD, et al. J Magn Reson Imaging. 2010 Jul;32(1):199-203. doi: 10.1002/jmri.22224. J Magn Reson Imaging. 2010. PMID: 20578027

31

Can diffusion-weighted imaging distinguish between normal and squamous cell carcinoma of the palatine tonsil?

Bhatia KS, King AD, Yeung DK, Mo F, Vlantis AC, Yu KH, Wong JK, Ahuja AT. Bhatia KS, et al. Among authors: king ad. Br J Radiol. 2010 Sep;83(993):753-8. doi: 10.1259/bjr/58331222. Epub 2010 Jul 20. Br J Radiol. 2010. PMID: 20647507 Free PMC article.

32

Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?

Bhatia KS, King AD, Yu KH, Vlantis AC, Tse GM, Mo FK, Ahuja AT. Bhatia KS, et al. Among authors: king ad. Br J Radiol. 2010 Nov;83(995):964-70. doi: 10.1259/bjr/27631720. Br J Radiol. 2010. PMID: 20965907 Free PMC article.

33

Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy.

King AD, Vlantis AC, Bhatia KS, Zee BC, Woo JK, Tse GM, Chan AT, Ahuja AT. King AD, et al. Radiology. 2011 Feb;258(2):531-7. doi: 10.1148/radiol.10101241. Epub 2010 Dec 3. Radiology. 2011. PMID: 21131580

34

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation.

Hui EP, Ma BBY, King AD, Mo F, Chan SL, Kam MKM, Loong HH, Ahuja AT, Zee BCY, Chan ATC. Hui EP, et al. Among authors: king ad. Ann Oncol. 2011 Jun;22(6):1280-1287. doi: 10.1093/annonc/mdq629. Epub 2011 Feb 11. Ann Oncol. 2011. PMID: 21317222 Free article. Clinical Trial.

35

Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers.

Lee FK, King AD, Ma BB, Yeung DK. Lee FK, et al. Among authors: king ad. Eur J Radiol. 2012 Apr;81(4):784-8. doi: 10.1016/j.ejrad.2011.01.089. Epub 2011 Mar 3. Eur J Radiol. 2012. PMID: 21376492

36

A five-colour colour-coded mapping method for DCE-MRI analysis of head and neck tumours.

Yuan J, Chow SK, Yeung DK, King AD. Yuan J, et al. Among authors: king ad. Clin Radiol. 2012 Mar;67(3):216-23. doi: 10.1016/j.crad.2011.07.052. Epub 2011 Sep 21. Clin Radiol. 2012. PMID: 21939962

37

A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Ma BBY, Kam MKM, Leung SF, Hui EP, King AD, Chan SL, Mo F, Loong H, Yu BKH, Ahuja A, Chan ATC. Ma BBY, et al. Among authors: king ad. Ann Oncol. 2012 May;23(5):1287-1292. doi: 10.1093/annonc/mdr401. Epub 2011 Sep 23. Ann Oncol. 2012. PMID: 21948811 Free article. Clinical Trial.

38

Nasopharyngeal mucosa and adenoids: appearance at MR imaging.

Bhatia KS, King AD, Vlantis AC, Ahuja AT, Tse GM. Bhatia KS, et al. Among authors: king ad. Radiology. 2012 May;263(2):437-43. doi: 10.1148/radiol.12111349. Epub 2012 Mar 8. Radiology. 2012. PMID: 22403169

39

Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

King AD, Chow KK, Yu KH, Mo FK, Yeung DK, Yuan J, Bhatia KS, Vlantis AC, Ahuja AT. King AD, et al. Radiology. 2013 Feb;266(2):531-8. doi: 10.1148/radiol.12120167. Epub 2012 Nov 14. Radiology. 2013. PMID: 23151830

40

T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.

King AD, Keung CK, Yu KH, Mo FK, Bhatia KS, Yeung DK, Tse GM, Vlantis AC, Ahuja AT. King AD, et al. AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1237-41. doi: 10.3174/ajnr.A3378. Epub 2013 Jan 10. AJNR Am J Neuroradiol. 2013. PMID: 23306012 Free PMC article.

41

Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.

Chan KC, Hung EC, Woo JK, Chan PK, Leung SF, Lai FP, Cheng AS, Yeung SW, Chan YW, Tsui TK, Kwok JS, King AD, Chan AT, van Hasselt AC, Lo YM. Chan KC, et al. Among authors: king ad. Cancer. 2013 May 15;119(10):1838-44. doi: 10.1002/cncr.28001. Epub 2013 Feb 21. Cancer. 2013. PMID: 23436393 Free article.

42

Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alpha.

Ma BB, Chan SL, Ho WM, Lau W, Mo F, Hui EP, Chan C, Poon A, Dattatray RD, Wong SC, To KF, King AD, Ahuja A, Chan AT. Ma BB, et al. Among authors: king ad. Cancer. 2013 Dec 1;119(23):4145-53. doi: 10.1002/cncr.28327. Epub 2013 Oct 1. Cancer. 2013. PMID: 24114668 Free article. Clinical Trial.

43

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).

Ma BB, Goh BC, Lim WT, Hui EP, Tan EH, Lopes Gde L, Lo KW, Li L, Loong H, Foster NR, Erlichman C, King AD, Kam MK, Leung SF, Chan KC, Chan AT. Ma BB, et al. Among authors: king ad. Invest New Drugs. 2015 Aug;33(4):985-91. doi: 10.1007/s10637-015-0264-0. Epub 2015 Jun 19. Invest New Drugs. 2015. PMID: 26084990 Clinical Trial.

44

Detection of Nasopharyngeal Carcinoma by MR Imaging: Diagnostic Accuracy of MRI Compared with Endoscopy and Endoscopic Biopsy Based on Long-Term Follow-Up.

King AD, Vlantis AC, Yuen TW, Law BK, Bhatia KS, Zee BC, Woo JK, Chan AT, Chan KC, Ahuja AT. King AD, et al. AJNR Am J Neuroradiol. 2015 Dec;36(12):2380-5. doi: 10.3174/ajnr.A4456. Epub 2015 Aug 27. AJNR Am J Neuroradiol. 2015. PMID: 26316564 Free PMC article.

45

Narrow band imaging endoscopy of the nasopharynx is not more useful than white light endoscopy for suspected nasopharyngeal carcinoma.

Vlantis AC, Woo JK, Tong MC, King AD, Goggins W, van Hasselt CA. Vlantis AC, et al. Among authors: king ad. Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3363-9. doi: 10.1007/s00405-016-3940-6. Epub 2016 Feb 20. Eur Arch Otorhinolaryngol. 2016. PMID: 26897607

46

Diffusion-Weighted Imaging of Nasopharyngeal Carcinoma: Can Pretreatment DWI Predict Local Failure Based on Long-Term Outcome?

Law BK, King AD, Bhatia KS, Ahuja AT, Kam MK, Ma BB, Ai QY, Mo FK, Yuan J, Yeung DK. Law BK, et al. Among authors: king ad. AJNR Am J Neuroradiol. 2016 Sep;37(9):1706-12. doi: 10.3174/ajnr.A4792. Epub 2016 May 5. AJNR Am J Neuroradiol. 2016. PMID: 27151750 Free PMC article.

47

Diffusion-weighted imaging of nasopharyngeal carcinoma to predict distant metastases.

Ai QY, King AD, Law BK, Yeung DK, Bhatia KS, Yuan J, Ahuja AT, Wong LY, Ma BB, Mo FK, Kam MK. Ai QY, et al. Among authors: king ad. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1045-1051. doi: 10.1007/s00405-016-4333-6. Epub 2016 Oct 8. Eur Arch Otorhinolaryngol. 2017. PMID: 27722898

48

Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.

Ma B, King AD, Leung L, Wang K, Poon A, Ho WM, Mo F, Chan CML, Chan ATC, Wong SCC. Ma B, et al. Among authors: king ad. Ann Oncol. 2017 Jul 1;28(7):1576-1581. doi: 10.1093/annonc/mdx149. Ann Oncol. 2017. PMID: 28379285 Free PMC article.

49

Prediction of distant metastases from nasopharyngeal carcinoma: Improved diagnostic performance of MRI using nodal volume in N1 and N2 stage disease.

Ai QY, King AD, Mo FKF, Law BKH, Bhatia KS, Ma BB, Poon DMC, Kam MKM. Ai QY, et al. Among authors: king ad. Oral Oncol. 2017 Jun;69:74-79. doi: 10.1016/j.oraloncology.2017.04.008. Epub 2017 Apr 18. Oral Oncol. 2017. PMID: 28559024

50

State of the art MRI in head and neck cancer.

Dai YL, King AD. Dai YL, et al. Among authors: king ad. Clin Radiol. 2018 Jan;73(1):45-59. doi: 10.1016/j.crad.2017.05.020. Epub 2017 Jun 24. Clin Radiol. 2018. PMID: 28655406 Review.

51

Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.

Chan KCA, Woo JKS, King A, Zee BCY, Lam WKJ, Chan SL, Chu SWI, Mak C, Tse IOL, Leung SYM, Chan G, Hui EP, Ma BBY, Chiu RWK, Leung SF, van Hasselt AC, Chan ATC, Lo YMD. Chan KCA, et al. N Engl J Med. 2017 Aug 10;377(6):513-522. doi: 10.1056/NEJMoa1701717. N Engl J Med. 2017. PMID: 28792880 Free article.

52

Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastases.

Ai QY, Hu CW, Bhatia KS, Poon DMC, Hui EP, Mo FKF, Law BKH, Tong M, Ma BB, Chan ATC, King AD. Ai QY, et al. Among authors: king ad. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):497-505. doi: 10.1007/s00405-017-4825-z. Epub 2017 Nov 29. Eur Arch Otorhinolaryngol. 2018. PMID: 29188437

53

MR Imaging Criteria for the Detection of Nasopharyngeal Carcinoma: Discrimination of Early-Stage Primary Tumors from Benign Hyperplasia.

King AD, Wong LYS, Law BKH, Bhatia KS, Woo JKS, Ai QY, Tan TY, Goh J, Chuah KL, Mo FKF, Chan KCA, Chan ATC, Vlantis AC. King AD, et al. AJNR Am J Neuroradiol. 2018 Mar;39(3):515-523. doi: 10.3174/ajnr.A5493. Epub 2017 Dec 28. AJNR Am J Neuroradiol. 2018. PMID: 29284600 Free PMC article.

54

Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study.

Hui EP, Ma BBY, Loong HHF, Mo F, Li L, King AD, Wang K, Ahuja AT, Chan CML, Hui CWC, Wong CH, Chan ATC. Hui EP, et al. Among authors: king ad. Clin Cancer Res. 2018 Mar 1;24(5):1030-1037. doi: 10.1158/1078-0432.CCR-17-1667. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301831 Clinical Trial.

55

Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.

Ma B, Hui EP, King A, Leung SF, Kam MK, Mo F, Li L, Wang K, Loong H, Wong A, Chan CM, Chan KCA, Wong SCC, Lo YMD, Chan AT. Ma B, et al. Br J Cancer. 2018 Apr;118(8):1051-1055. doi: 10.1038/s41416-018-0026-9. Epub 2018 Mar 20. Br J Cancer. 2018. PMID: 29555989 Free PMC article. Clinical Trial.

56

Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI?

Ai QY, King AD, Mo FKF, Law BKH, Bhatia KS, Poon DMC, Kam MKM, Ma BB. Ai QY, et al. Among authors: king ad. Clin Radiol. 2018 Jul;73(7):640-646. doi: 10.1016/j.crad.2017.12.015. Epub 2018 Apr 7. Clin Radiol. 2018. PMID: 29636188

57

Head and Neck Tumors: Amide Proton Transfer MRI.

Law BKH, King AD, Ai QY, Poon DMC, Chen W, Bhatia KS, Ahuja AT, Ma BB, Ka-Wai Yeung D, Fai Mo FK, Wang YX, Yuan J. Law BKH, et al. Among authors: king ad. Radiology. 2018 Sep;288(3):782-790. doi: 10.1148/radiol.2018171528. Epub 2018 Jun 12. Radiology. 2018. PMID: 29893646

58

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.

Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD. Chan ATC, et al. Among authors: king ad. J Clin Oncol. 2018 Jul 10:JCO2018777847. doi: 10.1200/JCO.2018.77.7847. Online ahead of print. J Clin Oncol. 2018. PMID: 29989858

59

Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment response.

Qamar S, King AD, Ai QY, Law BKH, Chan JSM, Poon DMC, Tong M, Mo FKF, Chen W, Bhatia KS, Ahuja AT, Ma BBY, Yeung DK, Wang YX, Yuan J. Qamar S, et al. Among authors: king ad. Eur Arch Otorhinolaryngol. 2019 Feb;276(2):505-512. doi: 10.1007/s00405-018-5231-x. Epub 2018 Dec 3. Eur Arch Otorhinolaryngol. 2019. PMID: 30511106

60

Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.

Ai QY, King AD, Poon DMC, Mo FKF, Hui EP, Tong M, Ahuja AT, Ma BBY, Chan ATC. Ai QY, et al. Among authors: king ad. Oral Oncol. 2019 Jan;88:124-130. doi: 10.1016/j.oraloncology.2018.11.007. Epub 2018 Nov 24. Oral Oncol. 2019. PMID: 30616782

61

Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.

Ai QY, King AD, Chan JSM, Chen W, Chan KCA, Woo JKS, Zee BCY, Chan ATC, Poon DMC, Ma BBY, Hui EP, Ahuja AT, Vlantis AC, Yuan J. Ai QY, et al. Among authors: king ad. Eur Radiol. 2019 Oct;29(10):5627-5634. doi: 10.1007/s00330-019-06133-8. Epub 2019 Mar 22. Eur Radiol. 2019. PMID: 30903340

62

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.

King AD, Woo JKS, Ai QY, Chan JSM, Lam WKJ, Tse IOL, Bhatia KS, Zee BCY, Hui EP, Ma BBY, Chiu RWK, van Hasselt AC, Chan ATC, Lo YMD, Chan KCA. King AD, et al. Ann Oncol. 2019 Jun 1;30(6):977-982. doi: 10.1093/annonc/mdz106. Ann Oncol. 2019. PMID: 30912815 Free article.

63

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

King AD, Woo JKS, Ai QY, Mo FKF, So TY, Lam WKJ, Tse IOL, Vlantis AC, Yip KWN, Hui EP, Ma BBY, Chiu RWK, Chan ATC, Lo YMD, Chan KCA. King AD, et al. AJNR Am J Neuroradiol. 2020 Mar;41(3):515-521. doi: 10.3174/ajnr.A6444. AJNR Am J Neuroradiol. 2020. PMID: 32184223 Free PMC article.

64

Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.

Hui EP, Li WF, Ma BB, Lam WKJ, Chan KCA, Mo F, Ai QYH, King AD, Wong CH, Guo R, Poon DMC, Tong M, Li L, Lau TKH, Wong KCW, Lam DCM, Lo YMD, Ma J, Chan ATC. Hui EP, et al. Among authors: king ad. Ann Oncol. 2020 Jun;31(6):769-779. doi: 10.1016/j.annonc.2020.03.289. Epub 2020 Mar 23. Ann Oncol. 2020. PMID: 32217076 Free article.

65

Pre-treatment intravoxel incoherent motion diffusion-weighted imaging predicts treatment outcome in nasopharyngeal carcinoma.

Qamar S, King AD, Ai QH, So TY, Mo FKF, Chen W, Poon DMC, Tong M, Ma BB, Hui EP, Yeung DK, Wang YX, Yuan J. Qamar S, et al. Among authors: king ad. Eur J Radiol. 2020 Aug;129:109127. doi: 10.1016/j.ejrad.2020.109127. Epub 2020 Jun 11. Eur J Radiol. 2020. PMID: 32563165

66

Intravoxel incoherent motion diffusion-weighted imaging for discrimination of benign and malignant retropharyngeal nodes.

So TY, Ai QH, Lam WKJ, Qamar S, Poon DMC, Hui EP, Mo FKF, Chan KCA, King AD. So TY, et al. Among authors: king ad. Neuroradiology. 2020 Dec;62(12):1667-1676. doi: 10.1007/s00234-020-02494-w. Epub 2020 Jul 16. Neuroradiology. 2020. PMID: 32676831

67

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx.

Ai QYH, Chen W, So TY, Lam WKJ, Jiang B, Poon DMC, Qamar S, Mo FKF, Blu T, Chan Q, Ma BBY, Hui EP, Chan KCA, King AD. Ai QYH, et al. Among authors: king ad. AJNR Am J Neuroradiol. 2020 Dec;41(12):2339-2344. doi: 10.3174/ajnr.A6828. Epub 2020 Oct 29. AJNR Am J Neuroradiol. 2020. PMID: 33122214 Free PMC article.

68

Convolutional neural network for discriminating nasopharyngeal carcinoma and benign hyperplasia on MRI.

Wong LM, King AD, Ai QYH, Lam WKJ, Poon DMC, Ma BBY, Chan KCA, Mo FKF. Wong LM, et al. Among authors: king ad. Eur Radiol. 2021 Jun;31(6):3856-3863. doi: 10.1007/s00330-020-07451-y. Epub 2020 Nov 25. Eur Radiol. 2021. PMID: 33241522

69

Test-retest repeatability of T1rho (T1ρ) MR imaging in the head and neck.

Ai QYH, Zhang H, Jiang B, So TY, Mo FKF, Qamar S, Chen W, King AD. Ai QYH, et al. Among authors: king ad. Eur J Radiol. 2021 Feb;135:109489. doi: 10.1016/j.ejrad.2020.109489. Epub 2020 Dec 24. Eur J Radiol. 2021. PMID: 33395595

70

Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI?

Wong LM, Ai QYH, Mo FKF, Poon DMC, King AD. Wong LM, et al. Among authors: king ad. Jpn J Radiol. 2021 Jun;39(6):571-579. doi: 10.1007/s11604-021-01092-x. Epub 2021 Feb 5. Jpn J Radiol. 2021. PMID: 33544302

71

Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer.

Hui EP, Ma BBY, Lam WKJ, Chan KCA, Mo F, Ai QH, King AD, Wong CH, Wong KCW, Lam DCM, Tong M, Poon DMC, Li L, Lau TKH, Wong KH, Lo YMD, Chan ATC. Hui EP, et al. Among authors: king ad. Clin Cancer Res. 2021 May 15;27(10):2827-2836. doi: 10.1158/1078-0432.CCR-20-3519. Epub 2021 Mar 10. Clin Cancer Res. 2021. PMID: 33692028

72

Nasopharyngeal carcinoma: an evolving paradigm.

Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To KF, King AD, Ma BBY, Chan ATC. Wong KCW, et al. Among authors: king ad. Nat Rev Clin Oncol. 2021 Nov;18(11):679-695. doi: 10.1038/s41571-021-00524-x. Epub 2021 Jun 30. Nat Rev Clin Oncol. 2021. PMID: 34194007 Review.

73

Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.

Liu Z, Li H, Yu KJ, Xie SH, King AD, Ai QH, Chen WJ, Chen XX, Lu ZJ, Tang LQ, Wang L, Xie CM, Ling W, Lu YQ, Huang QH, Coghill AE, Fakhry C, Pfeiffer RM, Zeng YX, Cao SM, Hildesheim A. Liu Z, et al. Among authors: king ad. Cancer. 2021 Sep 15;127(18):3403-3412. doi: 10.1002/cncr.33552. Epub 2021 Jul 7. Cancer. 2021. PMID: 34231883 Free article.

74

MR Imaging of Nasopharyngeal Carcinoma.

King AD. King AD. Magn Reson Imaging Clin N Am. 2022 Feb;30(1):19-33. doi: 10.1016/j.mric.2021.06.015. Magn Reson Imaging Clin N Am. 2022. PMID: 34802578 Free article. Review.

75

Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs.

Chen GH, Liu Z, Yu KJ, Coghill AE, Chen XX, Xie SH, Lin DF, Huang QH, Lu YQ, Ling W, Lin CY, Lu ZJ, Fan YY, Tang LQ, Sampson JN, Li H, King AD, Middeldorp JM, Hildesheim A, Cao SM. Chen GH, et al. Among authors: king ad. Clin Chem. 2022 Jul 3;68(7):953-962. doi: 10.1093/clinchem/hvac032. Clin Chem. 2022. PMID: 35325087

76

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.

Chan DCT, Lam WKJ, Hui EP, Ma BBY, Chan CML, Lee VCT, Cheng SH, Gai W, Jiang P, Wong KCW, Mo F, Zee B, King AD, Le QT, Chan ATC, Chan KCA, Lo YMD. Chan DCT, et al. Among authors: king ad. Ann Oncol. 2022 Aug;33(8):794-803. doi: 10.1016/j.annonc.2022.04.068. Epub 2022 Apr 29. Ann Oncol. 2022. PMID: 35491007 Free article.

77

Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis.

Ai QH, Hung KF, So TY, Mo FKF, Tsung Anthony Chin W, Hui EP, Ma BBY, Ying M, King AD. Ai QH, et al. Among authors: king ad. Cancer Imaging. 2022 May 20;22(1):24. doi: 10.1186/s40644-022-00462-6. Cancer Imaging. 2022. PMID: 35596198 Free PMC article. Review.

78

Imaging considerations for salvage surgery in nasopharyngeal carcinoma: what surgeons need to know.

Leung HS, King AD, Chow MWS, Lai CCF, Vlantis AC, Wong KT. Leung HS, et al. Among authors: king ad. Clin Radiol. 2022 Aug;77(8):592-599. doi: 10.1016/j.crad.2022.04.009. Epub 2022 May 20. Clin Radiol. 2022. PMID: 35599188 Review.

79

Radiomics for Discrimination between Early-Stage Nasopharyngeal Carcinoma and Benign Hyperplasia with Stable Feature Selection on MRI.

Wong LM, Ai QYH, Zhang R, Mo F, King AD. Wong LM, et al. Among authors: king ad. Cancers (Basel). 2022 Jul 14;14(14):3433. doi: 10.3390/cancers14143433. Cancers (Basel). 2022. PMID: 35884494 Free PMC article.

80

Discriminating between benign and malignant salivary gland tumors using diffusion-weighted imaging and intravoxel incoherent motion at 3 Tesla.

Zhang R, King AD, Wong LM, Bhatia KS, Qamar S, Mo FKF, Vlantis AC, Ai QYH. Zhang R, et al. Among authors: king ad. Diagn Interv Imaging. 2023 Feb;104(2):67-75. doi: 10.1016/j.diii.2022.08.003. Epub 2022 Sep 10. Diagn Interv Imaging. 2023. PMID: 36096875 Free article.

81

Normal size of benign upper neck nodes on MRI: parotid, submandibular, occipital, facial, retroauricular and level IIb nodal groups.

Ai QYH, So TY, Hung KF, King AD. Ai QYH, et al. Among authors: king ad. Cancer Imaging. 2022 Dec 8;22(1):66. doi: 10.1186/s40644-022-00504-z. Cancer Imaging. 2022. PMID: 36482491 Free PMC article.

82

Radiomics for Discriminating Benign and Malignant Salivary Gland Tumors; Which Radiomic Feature Categories and MRI Sequences Should Be Used?

Zhang R, Ai QYH, Wong LM, Green C, Qamar S, So TY, Vlantis AC, King AD. Zhang R, et al. Among authors: king ad. Cancers (Basel). 2022 Nov 25;14(23):5804. doi: 10.3390/cancers14235804. Cancers (Basel). 2022. PMID: 36497285 Free PMC article.

83

Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.

Lam WKJ, King AD, Miller JA, Liu Z, Yu KJ, Chua MLK, Ma BBY, Chen MY, Pinsky BA, Lou PJ, Woo JKS, Hsu WL, Simon J, Doolan DL, Waterboer T, Hui EP, Li H, Tsang RK, Wong KCW, Goh JP, Vlantis AC, Ai QY, Wong LM, Abdullah V, Lin JC, Chen CJ, Pfeiffer RM, Le QT, Lee AWM, Ji M, Cao S, Ma J, Chan ATC, Chan KCA, Hildesheim A. Lam WKJ, et al. Among authors: king ad. J Natl Cancer Inst. 2023 Apr 11;115(4):355-364. doi: 10.1093/jnci/djad012. J Natl Cancer Inst. 2023. PMID: 36723440 Free PMC article.

84

Radiologic extranodal extension for nodal staging in nasopharyngeal carcinoma.

Ai QYH, King AD, Yuan H, Vardhanabhuti V, Mo FKF, Hung KF, Hui EP, Kwong DL, Lee VH, Ma BBY. Ai QYH, et al. Among authors: king ad. Radiother Oncol. 2024 Feb;191:110050. doi: 10.1016/j.radonc.2023.110050. Epub 2023 Dec 13. Radiother Oncol. 2024. PMID: 38101457

85

Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.

King AD, Ai QYH, Lam WKJ, Tse IOL, So TY, Wong LM, Tsang JYM, Leung HS, Zee BCY, Hui EP, Ma BBY, Vlantis AC, van Hasselt AC, Chan ATC, Woo JKS, Chan KCA. King AD, et al. J Natl Cancer Inst. 2024 May 8;116(5):665-672. doi: 10.1093/jnci/djad260. J Natl Cancer Inst. 2024. PMID: 38171488

86

Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.

Chan KCA, Lam WKJ, King A, Lin VS, Lee PPH, Zee BCY, Chan SL, Tse IOL, Tsang AFC, Li MZJ, Jiang P, Ai QYH, Poon DMC, Au KH, Hui EP, Ma BBY, Van Hasselt AC, Chan ATC, Woo JKS, Lo YMD. Chan KCA, et al. NEJM Evid. 2023 Jul;2(7):EVIDoa2200309. doi: 10.1056/EVIDoa2200309. Epub 2023 Jun 27. NEJM Evid. 2023. PMID: 38320164

87

Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI.

Zhang R, Wong LM, So TY, Cai Z, Deng Q, Tsang YM, Ai QYH, King AD. Zhang R, et al. Among authors: king ad. Oral Oncol. 2024 May;152:106796. doi: 10.1016/j.oraloncology.2024.106796. Epub 2024 Apr 13. Oral Oncol. 2024. PMID: 38615586

88

Magnetic resonance imaging of the eustachian tube in nasopharyngeal carcinoma: correlation of patterns of spread with middle ear effusion.

King AD, Kew J, Tong M, Leung SF, Lam WW, Metreweli C, van Hasselt CA. King AD, et al. Am J Otol. 1999 Jan;20(1):69-73. Am J Otol. 1999. PMID: 9918176

89

MRI evaluation of multifidus muscles in adolescent idiopathic scoliosis.

Chan YL, Cheng JC, Guo X, King AD, Griffith JF, Metreweli C. Chan YL, et al. Among authors: king ad. Pediatr Radiol. 1999 May;29(5):360-3. doi: 10.1007/s002470050607. Pediatr Radiol. 1999. PMID: 10382215

90

MR features of the denervated tongue in radiation induced neuropathy.

King AD, Ahuja A, Leung SF, Chan YL, Lam WW, Metreweli C. King AD, et al. Br J Radiol. 1999 Apr;72(856):349-53. doi: 10.1259/bjr.72.856.10474495. Br J Radiol. 1999. PMID: 10474495

91

Hypoglossal nerve palsy in nasopharyngeal carcinoma.

King AD, Leung SF, Teo P, Lam WW, Chan YL, Metreweli C. King AD, et al. Head Neck. 1999 Oct;21(7):614-9. doi: 10.1002/(sici)1097-0347(199910)21:7<614::aid-hed5>3.0.co;2-i. Head Neck. 1999. PMID: 10487948

92

Sonographic appearances of preauricular sinus.

Ahuja AT, Marshall JN, Roebuck DJ, King AD, Metreweli C. Ahuja AT, et al. Among authors: king ad. Clin Radiol. 2000 Jul;55(7):528-32. doi: 10.1053/crad.1999.0479. Clin Radiol. 2000. PMID: 10924376

93

Sonographic evaluation of thyroglossal duct cysts in children.

Ahuja AT, King AD, Metreweli C. Ahuja AT, et al. Among authors: king ad. Clin Radiol. 2000 Oct;55(10):770-4. doi: 10.1053/crad.2000.0514. Clin Radiol. 2000. PMID: 11052878

94

Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns.

Kew J, King AD, Leung SF, Tong MC, Ku PK, Wong KK, van Hasselt CA. Kew J, et al. Among authors: king ad. Am J Otol. 2000 Nov;21(6):782-5. Am J Otol. 2000. PMID: 11078063

95

Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI.

King AD, Teo P, Lam WW, Leung SF, Metreweli C. King AD, et al. Clin Oncol (R Coll Radiol). 2000;12(6):397-402. doi: 10.1053/clon.2000.9199. Clin Oncol (R Coll Radiol). 2000. PMID: 11202093 Clinical Trial.

96

Nasopharyngeal carcinoma: dynamic MR imaging with gadolinium.

King AD, Lam WW, Leung SF, Chan YL, Metreweli C. King AD, et al. Chin Med J (Engl). 1998 Jul;111(7):593-8. Chin Med J (Engl). 1998. PMID: 11245043

97

MRI of primary non-Hodgkin's lymphoma of the palatine tonsil.

King AD, Lei KI, Ahuja AT. King AD, et al. Br J Radiol. 2001 Mar;74(879):226-9. doi: 10.1259/bjr.74.879.740226. Br J Radiol. 2001. PMID: 11338097

98

MR imaging features of nasopharyngeal tuberculosis: report of three cases and literature review.

King AD, Ahuja AT, Tse GM, van Hasselt AC, Chan AB. King AD, et al. AJNR Am J Neuroradiol. 2003 Feb;24(2):279-82. AJNR Am J Neuroradiol. 2003. PMID: 12591649 Free PMC article.

99

Tuberculosis of the nasopharynx: a rare entity revisited.

Tse GM, Ma TK, Chan AB, Ho FN, King AD, Fung KS, Ahuja AT. Tse GM, et al. Among authors: king ad. Laryngoscope. 2003 Apr;113(4):737-40. doi: 10.1097/00005537-200304000-00027. Laryngoscope. 2003. PMID: 12671437

100

A case of big bad bones.

Richards PS, King AD. Richards PS, et al. Among authors: king ad. Br J Radiol. 2003 Jul;76(907):503-4. doi: 10.1259/bjr/56902821. Br J Radiol. 2003. PMID: 12857712 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page